In a landmark move for medical innovation in the Middle East, Burjeel Hospital Abu Dhabi has announced a strategic partnership with South Korea’s ARPI Inc. The Memorandum of Understanding (MoU), signed at the prestigious Abu Dhabi Future Health Summit 2026, aims to integrate AI-powered electrocardiogram (ECG) interpretation into clinical practice. This collaboration marks a significant step forward in cardiovascular care, aligning with the ambitious Burjeel 2.0 transformation strategy.
### Advancing Early Detection through AI Innovation
At the heart of this agreement is **ECG Buddy**, an advanced AI-powered clinical decision-support solution developed by ARPI Inc. As reported by **Business Promotion24**, this technology is designed to assist healthcare professionals in identifying cardiac rhythm abnormalities with greater precision. By leveraging artificial intelligence, Burjeel Hospital seeks to enhance the early identification of cardiovascular diseases, enabling physicians to make more informed, timely decisions.
The partnership focuses on clinical validation within Burjeel’s world-class facilities. With ECG Buddy already holding CE certification and regulatory approval from South Korea’s Ministry of Food and Drug Safety, the pilot implementation in Abu Dhabi will assess its performance and clinical utility within the local healthcare landscape.
### Strengthening the Burjeel 2.0 Strategy
The collaboration is a cornerstone of **Burjeel 2.0**, the Group’s strategic roadmap dedicated to clinical excellence and the adoption of cutting-edge technology. Dr. Shamsheer Vayalil, Chairman and CEO of Burjeel Holdings, and H.E. Lee Won-ik, Ambassador of the Republic of Korea to the UAE, were present at the signing, highlighting the international significance of this UAE-South Korea healthcare alliance.
Dr. Georgie Thomas, Head of Cardiology at Burjeel Hospital Abu Dhabi, emphasized the importance of this shift: “AI can help physicians recognize key diagnostic signals earlier. Through this collaboration, we want to ensure that innovation translates into better outcomes for our patients.”
### A Hub for Cardiovascular Excellence
Burjeel Hospital is already a leader in cardiac care, recently introducing one of the GCC’s first AI-powered catheterization laboratories. This facility utilizes the Siemens Healthineers’ ARTIS icono.vision platform, which offers 3D visualization and real-time guidance for complex heart procedures. The addition of ARPI’s AI ECG technology creates a comprehensive, tech-driven ecosystem—from initial diagnosis to advanced surgical intervention.
### Future Outlook for the MENA Region
As **Business Promotion24** monitors the evolving healthcare sector, it is clear that this partnership holds potential beyond Abu Dhabi. The agreement includes plans for a joint working group to explore wider implementation across the GCC and the broader Middle East and North Africa (MENA) region.
By combining South Korean technological expertise with Burjeel’s clinical mastery, the UAE continues to solidify its position as a global hub for medical tourism and health innovation. This initiative ensures that patients in the region have access to the most advanced diagnostic tools available in modern medicine today.
